Arvinas Total Shareholders Equity 2011-2026 | ARVN

Annual Total Shareholders Equity Arvinas

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
434 M	562 M	660 M	565 M	782 M	642 M	227 M	137 M	-61.2 M	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
782 M	-61.2 M	439 M

Quarterly Total Shareholders Equity Arvinas

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
564 M	609 M	660 M	562 M	586 M	600 M	610 M	660 M	457 M	464 M	511 M	565 M	622 M	671 M	723 M	782 M	818 M	583 M	615 M	642 M	642 M	642 M	642 M	227 M	227 M	227 M	227 M	137 M	137 M	137 M	137 M	-61.2 M	-61.2 M	-	-	-32.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
818 M	-61.2 M	457 M

Total Shareholders Equity of other stocks in the Biotechnology industry

Issuer	Total Shareholders Equity	Price	% 24h	Market Cap	Country
Amgen AMGN	8.66 B	$ 350.13	2.98 %	$ 188 B	USA
MorphoSys AG MOR	621 M	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	-158 M	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	70.7 M	-	-	$ 86.2 M	USA
Amneal Pharmaceuticals AMRX	-70.8 M	$ 12.73	3.33 %	$ 3.99 B	USA
AlloVir ALVR	78.8 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	60.8 M	-	-	$ 10.1 M	USA
Autolus Therapeutics plc AUTL	178 M	$ 1.48	8.82 %	$ 394 M	Britain
Applied Therapeutics APLT	-17.1 M	-	-	$ 8.42 M	USA
I-Mab IMAB	1.72 B	-	-	$ 866 M	China
Genfit SA GNFT	-16.2 M	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	189 M	$ 24.57	5.59 %	$ 3.13 B	USA
Biophytis SA BPTS	2.27 M	-	-13.47 %	$ 169 M	France
AVROBIO AVRO	94.7 M	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	-1.1 M	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	15.6 B	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	6.72 M	-	-18.52 %	$ 27.3 M	Britain
BioNTech SE BNTX	1.37 B	$ 91.64	2.25 %	$ 27.2 B	Germany
BeiGene, Ltd. BGNE	4.36 B	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	35.5 M	$ 3.82	1.6 %	$ 9.19 B	Australia
Burford Capital Limited BUR	1.7 B	$ 4.62	1.54 %	$ 742 M	Britain
CymaBay Therapeutics CBAY	292 M	-	-	$ 3.45 B	USA
Advaxis ADXS	-24.4 M	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	19 M	$ 2.68	4.28 %	$ 16.8 M	USA
Avid Bioservices CDMO	60.9 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	163 M	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	5.44 M	$ 3.05	0.66 %	$ 6.64 B	Israel
Cabaletta Bio CABA	112 M	$ 3.05	-0.5 %	$ 306 M	USA
Checkpoint Therapeutics CKPT	-12.6 M	-	-	$ 169 M	USA
Checkmate Pharmaceuticals CMPI	69.5 M	-	-	$ 231 M	USA
Cerus Corporation CERS	64.2 M	$ 1.93	4.62 %	$ 368 M	USA
AgeX Therapeutics AGE	-37 K	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	112 M	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	715 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	29.5 M	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	-17.6 M	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	69.4 M	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	-27.2 M	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	6.84 M	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	8.54 M	$ 2.83	2.91 %	$ 7.38 M	USA
Deciphera Pharmaceuticals DCPH	351 M	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	750 M	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	597 M	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	688 M	-	-	$ 867 M	Germany
Coherus BioSciences CHRS	61 M	$ 1.73	3.59 %	$ 203 M	USA